3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Osteosarcoma
1
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Interventions
Neuropsychological Tests
2
Vitamin D
1
Standard of Care
1
Silymarin
1
Physical Conditioning, Human
1
Patient Reported Outcome Measures
1
Mindfulness
1
Geriatric Assessment
1
Exergaming
1
Counseling
1
Coping Skills
1
Cognitive Training
1
Blood Specimen Collection
1
Aspirin
1
Ashwagandha
1
Anticonvulsants
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Cognitive Dysfunction
×
Ashwagandha
×
Clear all
NCT04092647
2023-06-15
Ashwagandha for Cognitive Dysfunction
Sutter Health
Phase 2
Unknown
80 enrolled